CATHERINE FARINET: Open Payments
NPI 1801821723 · PIKETON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 36 payments from 17 companies in 2025. Trend: 2023 $303 · 2024 $607 · 2025 $621
Food & beverage: $576Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $170 |
| Lilly USA, LLC | 3 | $80 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Novo Nordisk Inc | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $20 |
Products named: VRAYLAR, UBRELVY, INGREZZA, REXULTI, XIFAXAN, MOUNJARO, QULIPTA, INSPIRE.
Industry payments across OH — which companies pay providers there.
